[PDF][PDF] Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250
MG Steffens, OC Boerman, JC Oosterwijk-Wakka… - 1997 - repository.ubn.ru.nl
Results: In all patients with antigen-positive tumors (n= 13), the primary tumors and all
known metastases were clearly visualized. Overall uptake, expressed as the percentage of …
known metastases were clearly visualized. Overall uptake, expressed as the percentage of …
Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
D Piwnica-Worms - US Patent 6,348,185, 2002 - Google Patents
Methods and compositions for medical imaging, evaluating intracellular processes and
components, radiotherapy of intracellular targets, and drug delivery by the use of novel cell …
components, radiotherapy of intracellular targets, and drug delivery by the use of novel cell …
Amino acid infusion blocks renal tubular uptake of an indium-labelled somatostatin analogue
PJ Hammond, AF Wade, ME Gwilliam… - British journal of …, 1993 - nature.com
The Indium-labelled somatostatin analogue pentetreotide has been successfully developed
for imaging of somatostatin receptor positive tumours. However there is significant renal …
for imaging of somatostatin receptor positive tumours. However there is significant renal …
[PDF][PDF] Absolute organ activity estimated by five different methods of background correction
WCAM Buijs, JA Siegel, OC Boerman… - Journal of Nuclear …, 1998 - Soc Nuclear Med
+ 39%. Conclusion: Even though quantitative SPECT is the most rigorous method for activity
quantification in conditions of low organ-to-background activity concentration ratio, planar …
quantification in conditions of low organ-to-background activity concentration ratio, planar …
[HTML][HTML] Safety and biodistribution of 111In-amatuximab in patients with mesothelin expressing cancers using single photon emission computed tomography …
L Lindenberg, A Thomas, S Adler, E Mena, K Kurdziel… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Amatuximab is a chimeric high-affinity monoclonal IgG1/k antibody targeting mesothelin that
is being developed for treatment of mesothelin-expressing cancers. Considering the …
is being developed for treatment of mesothelin-expressing cancers. Considering the …
Chemical design of radiolabeled antibody fragments for low renal radioactivity levels
Y Arano, Y Fujioka, H Akizawa, M Ono, T Uehara… - Cancer research, 1999 - AACR
The renal uptake of radiolabeled antibody fragments presents a problem in targeted imaging
and therapy. We hypothesized that the renal radioactivity levels of radiolabeled antibody …
and therapy. We hypothesized that the renal radioactivity levels of radiolabeled antibody …
99mTc-labeled interleukin 8 for the scintigraphic detection of infection and inflammation: first clinical evaluation
CP Bleeker-Rovers, HJJM Rennen… - Journal of Nuclear …, 2007 - Soc Nuclear Med
Interleukin 8 (IL-8) is a chemotactic cytokine that binds with a high affinity to receptors
expressed on neutrophils. Previous studies with various animal models showed that 99mTc …
expressed on neutrophils. Previous studies with various animal models showed that 99mTc …
Pharmacokinetics, biodistribution and biological effects of intravenously administered bispecific monoclonal antibody OC/TR F(ab′)2 in ovarian carcinoma patients
JG Tibben, OC Boerman… - … journal of cancer, 1996 - Wiley Online Library
The bispecific monoclonal antibody (biMAb) OC/TR combines the anti‐ovarian‐cancer
reactivity of the MOv18 monoclonal antibody (MAb) with the reactivity of an anti‐CD3 MAb …
reactivity of the MOv18 monoclonal antibody (MAb) with the reactivity of an anti‐CD3 MAb …
Targeting of Metastatic Renal Cell Carcinoma with the Chimeric Monoclonal Antibody G250 Labeled with 131I or 111In: An Intrapatient Comparison
AH Brouwers, WCAM Buijs, E Oosterwijk… - Clinical cancer …, 2003 - AACR
Purpose: There is increasing evidence that the chimeric monoclonal antibody G250 (cG250)
can be internalized by G250 antigen-expressing renal cell carcinoma (RCC) cells. Thus …
can be internalized by G250 antigen-expressing renal cell carcinoma (RCC) cells. Thus …
Analysis of absorbed dose in radioimmunotherapy with 177Lu-trastuzumab using two different imaging scenarios: a pilot study
Objectives Internal organ dosimetry is an important procedure to demonstrate the reliable
application of 177 Lu-trastuzumab radioimmunotherapy for human epidermal growth factor …
application of 177 Lu-trastuzumab radioimmunotherapy for human epidermal growth factor …